Cytochrome P450 2C is an EDHF synthase in coronary arteries
- 1 September 1999
- journal article
- letter
- Published by Springer Nature in Nature
- Vol. 401 (6752) , 493-497
- https://doi.org/10.1038/46816
Abstract
In most arterial beds a significant endothelium-dependent dilation to various stimuli persists even after inhibition of nitric oxide synthase and cyclo-oxygenase. This dilator response is preceded by an endothelium-dependent hyperpolarization of vascular smooth muscle cells, which is sensitive to a combination of the calcium-dependent potassium-channel inhibitors charybdotoxin and apamin, and is assumed to be mediated by an unidentified endothelium-derived hyperpolarizing factor (EDHF)1,2. Here we show that the induction of cytochrome P450 (CYP) 2C8/34 in native porcine coronary artery endothelial cells by β-naphthoflavone enhances the formation of 11,12-epoxyeicosatrienoic acid, as well as EDHF-mediated hyperpolarization and relaxation. Transfection of coronary arteries with CYP 2C8/34 antisense oligonucleotides results in decreased levels of CYP 2C and attenuates EDHF-mediated vascular responses. Thus, a CYP-epoxygenase product is an essential component of EDHF-mediated relaxation in the porcine coronary artery, and CYP 2C8/34 fulfils the criteria for the coronary EDHF synthase.Keywords
This publication has 18 references indexed in Scilit:
- Simultaneous Analysis of 4- and 5-Series Lipoxygenase and Cytochrome P450 Products from Different Biological Sources by Reversed-Phase High-Performance Liquid Chromatographic TechniqueAnalytical Biochemistry, 1998
- Hyperpolarizing FactorsBiochemical Pharmacology, 1997
- A transferable, beta-naphthoflavone-inducible, hyperpolarizing factor is synthesized by native and cultured porcine coronary endothelial cells.The Journal of Physiology, 1996
- Nitric Oxide Attenuates the Release of Endothelium-Derived Hyperpolarizing FactorCirculation, 1996
- Identification of Epoxyeicosatrienoic Acids as Endothelium-Derived Hyperpolarizing FactorsCirculation Research, 1996
- Interaction of Sulfaphenazole Derivatives with Human Liver Cytochromes P450 2C: Molecular Origin of the Specific Inhibitory Effects of Sulfaphenazole on CYP 2C9 and Consequences for the Substrate Binding Site Topology of CYP 2C9Biochemistry, 1996
- Cytochrome P450-dependent effects of bradykinin in the rat heartBritish Journal of Pharmacology, 1995
- Characterization of endothelium‐derived hyperpolarizing factor as a cytochrome P450‐derived arachidonic acid metabolite in mammals.The Journal of Physiology, 1994
- Display of the characteristics of endothelium‐derived hyperpolarizing factor by a cytochrome P450‐derived arachidonic acid metabolite in the coronary microcirculationBritish Journal of Pharmacology, 1994
- Acetylcholine releases endothelium‐derived hyperpolarizing factor and EDRF from rat blood vesselsBritish Journal of Pharmacology, 1988